(Q46244368)

English

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

C Blake Gilks

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

author name string

Joshua Z Press

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Jennifer A Kenyon

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Hui Xue

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Melinda A Miller

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Alessandro De Luca

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Dianne M Miller

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

David G Huntsman

7

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Jessica N McAlpine

9

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Y Z Wang

10

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

language of work or name

0 references

publication date

10 June 2008

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Gynecologic Oncology

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

110

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

256-264

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived—But They Can Be Improved

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Mouse models of gynecologic pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Morphological effects of chemotherapy on ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Targeting the DNA repair defect of BRCA tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.011

7 January 2021

Identifiers

10.1016/J.YGYNO.2008.03.011

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/18547621

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46244368&oldid=2102091388"